Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

PFIZER vs LUPIN - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More


Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More


Current Valuations

P/E (TTM) x 34.3 40.5 84.7% View Chart
P/BV x 5.4 2.5 218.4% View Chart
Dividend Yield % 0.6 0.7 94.0%  


5-Yr Chart
Click to enlarge
High Rs2,3651,465 161.4%   
Low Rs1,625727 223.5%   
Sales per share (Unadj.) Rs430.3349.6 123.1%  
Earnings per share (Unadj.) Rs78.75.6 1,416.1%  
Cash flow per share (Unadj.) Rs93.229.6 315.1%  
Dividends per share (Unadj.) Rs20.005.00 400.0%  
Dividend yield (eoy) %1.00.5 219.8%  
Book value per share (Unadj.) Rs586.5300.3 195.3%  
Shares outstanding (eoy) m45.75452.08 10.1%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x4.63.1 147.9%   
Avg P/E ratio x25.3197.2 12.9%  
P/CF ratio (eoy) x21.437.1 57.8%  
Price / Book Value ratio x3.43.6 93.2%  
Dividend payout %25.490.0 28.2%   
Avg Mkt Cap Rs m91,271495,502 18.4%   
No. of employees `0002.617.0 15.4%   
Total wages/salary Rs m3,14328,647 11.0%   
Avg. sales/employee Rs Th7,484.89,273.6 80.7%   
Avg. wages/employee Rs Th1,195.01,681.0 71.1%   
Avg. net profit/employee Rs Th1,369.1147.4 928.6%   
Net Sales Rs m19,685158,042 12.5%  
Other income Rs m1,1431,504 76.0%   
Total revenues Rs m20,828159,545 13.1%   
Gross profit Rs m5,00331,475 15.9%  
Depreciation Rs m66310,859 6.1%   
Interest Rs m42,044 0.2%   
Profit before tax Rs m5,47920,076 27.3%   
Minority Interest Rs m0-71 0.0%   
Prior Period Items Rs m035 0.0%   
Extraordinary Inc (Exp) Rs m0-14,644 0.0%   
Tax Rs m1,8782,885 65.1%   
Profit after tax Rs m3,6012,513 143.3%  
Gross profit margin %25.419.9 127.6%  
Effective tax rate %34.314.4 238.6%   
Net profit margin %18.31.6 1,150.5%  
Current assets Rs m24,167122,095 19.8%   
Current liabilities Rs m9,54450,956 18.7%   
Net working cap to sales %74.345.0 165.0%  
Current ratio x2.52.4 105.7%  
Inventory Days Days5585 65.1%  
Debtors Days Days29120 23.9%  
Net fixed assets Rs m9,514129,876 7.3%   
Share capital Rs m458904 50.6%   
"Free" reserves Rs m26,375134,866 19.6%   
Net worth Rs m26,832135,771 19.8%   
Long term debt Rs m2564,245 0.0%   
Total assets Rs m36,900263,054 14.0%  
Interest coverage x1,305.510.8 12,061.0%   
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.50.6 88.8%   
Return on assets %9.81.7 564.1%  
Return on equity %13.41.9 725.1%  
Return on capital %20.43.7 548.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2253,141 0.0%   
Fx outflow Rs m1,48919,335 7.7%   
Net fx Rs m-1,46633,807 -4.3%   
From Operations Rs m3,31817,512 18.9%  
From Investments Rs m-2,383-14,073 16.9%  
From Financial Activity Rs m-1,104-14,921 7.4%  
Net Cashflow Rs m-169-11,482 1.5%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 63.9 0.2 31,950.0%  
Indian inst/Mut Fund % 7.5 11.3 66.4%  
FIIs % 4.9 31.9 15.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 10.1 234.7%  
Shareholders   85,207 98,259 86.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster


Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Today's Market

Sensex Ends 382 Points Lower; Auto and Telecom Stocks Witness Selling(Closing)

India share markets witnessed huge selling pressure during closing hours and ended their trading session deep in the red.

Related Views on News

PFIZER Surges by 5%; BSE HEALTHCARE Index Up 0.3% (Market Updates)

May 21, 2019 | Updated on May 21, 2019

PFIZER share price has surged by 5% and its current market price is Rs 3,222. The BSE HEALTHCARE is up by 0.3%. The top gainers in the BSE HEALTHCARE Index are PFIZER (up 5.3%) and CAPLIN POINT (up 5.5%). The top losers are CADILA HEALTHCARE (down 0.1%) and SUN PHARMA ADV. RES. (down 0.1%).

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

More Views on News

Most Popular

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


May 21, 2019 (Close)